Welcome to LookChem.com Sign In|Join Free
  • or
2-(chlorocarbonyl)phenyl 2-(acetyloxy)benzoate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1003572-58-4

Post Buying Request

1003572-58-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1003572-58-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1003572-58-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,3,5,7 and 2 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1003572-58:
(9*1)+(8*0)+(7*0)+(6*3)+(5*5)+(4*7)+(3*2)+(2*5)+(1*8)=104
104 % 10 = 4
So 1003572-58-4 is a valid CAS Registry Number.

1003572-58-4Relevant academic research and scientific papers

COMPOSITIONS FOR THE TREATMENT OF DIABETES AND PRE-DIABETES

-

Paragraph 0135; 0137, (2014/12/09)

The invention relates to the compositions of formula I or its pharmaceutical acceptable polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprises a salt of metformin and the methods for treating or preventing metabolic syndrome, prediabetes and diabetes may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of diabetes mellitus, obesity, lipid disorders, hypertriglyceridemia, hyperglycemia, hyperinsulinemia and insulin resistance.

COMPOSITIONS AND METHODS FOR THE TREATMENT OF DIABETES AND PRE-DIABETES

-

Paragraph 00125; 00127, (2015/01/06)

The invention relates to the compositions of formula I or its pharmaceutical acceptable polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprises a salt of metformin and the methods for treating or preventing metabolic syndrome, prediabetes and diabetes may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of diabetes mellitus, obesity, lipid disorders, hypertriglyceridemia, hyperglycemia, hyperinsulinemia and insulin resistance.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1003572-58-4